Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (September 2022)
Adarsh Bhimraj, Rebecca L. Morgan, Amy Hirsch Shumaker, et al.
Clinical Infectious Diseases (2022) Vol. 78, Iss. 7, pp. e250-e349
Open Access | Times Cited: 128

Showing 1-25 of 128 citing articles:

Therapeutic strategies for COVID-19: progress and lessons learned
Guangdi Li, Rolf Hilgenfeld, Richard J. Whitley, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 6, pp. 449-475
Open Access | Times Cited: 411
REVIEW OF LABORATORY DIAGNOSTICS EVOLUTION IN NIGERIA'S RESPONSE TO COVID-19
Chinedu Paschal Maduka, Adebukola Adejumoke Adegoke, Chiamaka Chinaemelum Okongwu, et al.
International Medical Science Research Journal (2023) Vol. 3, Iss. 1, pp. 1-23
Open Access | Times Cited: 66
ICU-acquired infections in immunocompromised patients
Louis Kreitmann, Julie Helms, Ignacio Martín‐Loeches, et al.
Intensive Care Medicine (2024) Vol. 50, Iss. 3, pp. 332-349
Closed Access | Times Cited: 32
Oral Antiviral Treatment for COVID-19: A Comprehensive Review on Nirmatrelvir/Ritonavir
Karolina Akinosoglou, Georgios Schinas, Charalambos Gogos
Viruses (2022) Vol. 14, Iss. 11, pp. 2540-2540
Open Access | Times Cited: 55
Evolution and Control of COVID-19 Epidemic in Hong Kong
Shuk‐Ching Wong, Albert Ka-Wing Au, Janice Lo, et al.
Viruses (2022) Vol. 14, Iss. 11, pp. 2519-2519
Open Access | Times Cited: 51
Coronavirus Disease 2019 Convalescent Plasma Outpatient Therapy to Prevent Outpatient Hospitalization: A Meta-Analysis of Individual Participant Data From 5 Randomized Trials
Adam C. Levine, Yuriko Fukuta, Moisés A. Huamán, et al.
Clinical Infectious Diseases (2023) Vol. 76, Iss. 12, pp. 2077-2086
Open Access | Times Cited: 40
Clinical course and management of COVID-19 in the era of widespread population immunity
Eric A. Meyerowitz, Jake Scott, Aaron Richterman, et al.
Nature Reviews Microbiology (2023) Vol. 22, Iss. 2, pp. 75-88
Closed Access | Times Cited: 36
Remdesivir for the Treatment of COVID-19: A Narrative Review
Patrick O. Godwin, Bryan Polsonetti, Michael F. Caron, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 1, pp. 1-19
Open Access | Times Cited: 12
The efficacy of antivirals, corticosteroids, and monoclonal antibodies as acute COVID-19 treatments in reducing the incidence of long COVID: a systematic review and meta-analysis
Gangqiang Sun, Ke Lin, Jingwen Ai, et al.
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 12, pp. 1505-1513
Closed Access | Times Cited: 9
Tracing Emergence of SARS-CoV-2 Variants: Insights from Comprehensive Assessment Using Reverse Transcription Polymerase Chain Reaction and Whole Genome Sequencing
D. Na, Yuna Hong, C. Lee, et al.
Microorganisms (2025) Vol. 13, Iss. 2, pp. 311-311
Open Access | Times Cited: 1
Trends in Respiratory Pathogen Testing at US Children’s Hospitals
Matthew J. Molloy, Matthew Hall, Jessica L. Markham, et al.
JAMA Network Open (2025) Vol. 8, Iss. 3, pp. e250160-e250160
Open Access | Times Cited: 1
Risk of hospitalization and sequelae in patients with COVID‐19 treated with 3‐day early remdesivir vs. controls in the vaccine and Omicron era: A real‐life cohort study
Maria Mazzitelli, Mattia Trunfio, Lolita Sasset, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 3
Closed Access | Times Cited: 22
Cytokine Storm in COVID-19: Exploring IL-6 Signaling and Cytokine-Microbiome Interactions as Emerging Therapeutic Approaches
Tudorița Gabriela Părângă, Ivona Mitu, Mariana Pavel, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11411-11411
Open Access | Times Cited: 6
Remdesivir Is Associated With Reduced Mortality in COVID-19 Patients Requiring Supplemental Oxygen Including Invasive Mechanical Ventilation Across SARS-CoV-2 Variants
Essy Mozaffari, Aastha Chandak, Robert Gottlieb, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 10
Open Access | Times Cited: 15
Aurones: A Promising Scaffold to Inhibit SARS-CoV-2 Replication
Guilherme S. Caleffi, Alice dos Santos Rosa, Luana G. de Souza, et al.
Journal of Natural Products (2023) Vol. 86, Iss. 6, pp. 1536-1549
Closed Access | Times Cited: 14
Clinical effectiveness of oral antiviral agents in older patients with COVID‐19 based on real‐world data
Ya‐Wen Tsai, Jheng‐Yan Wu, Tinghui Liu, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Closed Access | Times Cited: 14
Methods for living guidelines: early guidance based on practical experience. Paper 4: search methods and approaches for living guidelines
Steve McDonald, Steve Sharp, Rebecca L. Morgan, et al.
Journal of Clinical Epidemiology (2023) Vol. 155, pp. 108-117
Open Access | Times Cited: 13
The safety and effectiveness of remdesivir in a postmarketing surveillance study in Japan
Jami Peters, Lindsey Force, Leslie J. Ng, et al.
Respiratory Investigation (2024) Vol. 62, Iss. 2, pp. 192-199
Closed Access | Times Cited: 5
Effectiveness of Nirmatrelvir-Ritonavir for the Prevention of COVID-19–Related Hospitalization and Mortality: A Systematic Literature Review
A. Cha-Silva, M. Gavaghan, Tobias Bergroth, et al.
American Journal of Therapeutics (2024) Vol. 31, Iss. 3, pp. e246-e257
Open Access | Times Cited: 5
SARS-CoV-2 Vaccines: The Advantage of Mucosal Vaccine Delivery and Local Immunity
Joshua Tobias, Peter Steinberger, Joy Wilkinson, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 795-795
Open Access | Times Cited: 5
Does early combination vs. Monotherapy improve clinical outcomes of clinically extremely vulnerable patients with COVID-19? Results from a retrospective propensity-weighted analysis
Maria Mazzitelli, Alberto Enrico Maraolo, Claudia Cozzolino, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 5
Tocilizumab for Patients with Severe Fever with Thrombocytopenia Syndrome: Tocilizumab Observational SFTS Study-1
Jeong Rae Yoo, Mi-Sun Kim, Myeong Jin Kang, et al.
Yonsei Medical Journal (2025) Vol. 66, Iss. 5, pp. 321-321
Open Access
Peer-to-peer tele-consultative services for critical care, Afghanistan, Kenya, Pakistan, United Republic of Tanzania
Asad Latif, Huba Atiq, Mareeha Zaki, et al.
Bulletin of the World Health Organization (2025) Vol. 103, Iss. 02, pp. 90-98
Open Access
Factors associated with glucocorticoid dosing in treating patients with noncritical COVID-19 pneumonia: Insights from an artificial intelligence-based CT imaging analysis
Jie Wang, Chang He, Yu Shi, et al.
Enfermedades Infecciosas y Microbiología Clínica (2025)
Closed Access
Experiences of working as a clinical nurse while pregnant during the coronavirus disease-2019 pandemic: a qualitative study
Lin Wu, Wing Fai Yeung, Yao Pei, et al.
BMC Nursing (2025) Vol. 24, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top